AChE inhibitors are the most effective approach to treat the cognitive symptoms of Alzheimer disease and other possible therapeutic applications in the treatment of Parkinson.s disease, senile dementia, and ataxia, among others. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.